Trial Information

Nabucco - Non-Interventional Study to Investigate Efficacy and Safety of Nab-Paclitaxel in Patients With Metastatic Breast Cancer

The main focus of this non-interventional study is set on answering the following questions:

- Can the results observed in controlled clinical trials regarding efficacy and safety be
reproduced in the routine clinical setting?

- Are the side-effects of nab-paclitaxel therapy observed in this study comparable to the
previously described safety-profile in terms of frequency and intensity?

- What are the main reasons for modification or termination of the nab-paclitaxel
therapy?

- How does nab-paclitaxel therapy influence the patients' quality of life?

- What are the criteria for selecting nab-paclitaxel as therapy for metastatic breast
cancer?